PhoreMost is a new-model drug discovery company dedicated to ‘Drugging the Undruggable®’ PhoreAll and PhoreEST are our dedicated inclusion & green initiatives." title="" class="btn" data-container="body" data-html="true" data-id="285553" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="PhoreMost"> 620 5,406
Activities
Technologies
Entity types
Location
Unity Campus, Cambridge CB22 3FT, UK
Pampisford
United Kingdom
Employees
Scale: 11-50
Estimated: 49
Engaged corporates
5Added in Motherbase
1 year, 11 months agoDrugging the Undruggable®
PhoreMost is a new-model drug discovery company based in Cambridge, UK. We are dedicated to ‘Drugging the Undruggable®’ disease targets using our next-generation technology, SITESEEKER®. Using PROTEINi® libraries, this unique drug target identification platform can discern the best new targets for future therapy and crucially, how to drug them, which has the potential to significantly increase the diversity and affordability of novel therapeutics for cancer and other unmet diseases.
PhoreMost is building a pipeline of novel drug discovery programmes aimed at addressing a range of diseases, with a mission to accelerate, diversify and rationalise drug discovery. Using this core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savings onto patients.
We realise that we can’t progress our mission alone, and so are committed to forging a new model of drug discovery, working in partnership across both academia and industry to realise this vision.
We are committed to being an open, inclusive and responsible company, PhoreAll and PhorEST being our dedicated inclusion and green initiatives.
Please contact us to learn more: https://www.phoremost.com/contact
Drug discovery & development, Biotechnology, Oncology, Target discovery, and Platform technology development
Through its SITESEEKER® drug target identification platform, PhoreMost is expanding druggable space. In partnership, we are discovering and developing the …
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() IP Group plc Financial Services | IP Group plc Financial Services | Other 19 Oct 2023 | | |
![]() Amazon Web Services (AWS) IT services, IT Services and IT Consulting | Amazon Web Services (AWS) IT services, IT Services and IT Consulting | Other 18 Oct 2023 | | |
![]() UK Research and Innovation Public business cluster, Government Administration | UK Research and Innovation Public business cluster, Government Administration | Other 13 Jun 2018 | | |
![]() Cambridge Enterprise Startup accelerator & VC, Higher Education | Cambridge Enterprise Startup accelerator & VC, Higher Education | Other 24 Oct 2024 | | |
![]() Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 21 Aug 2024 | |